This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of ClinicalDevelopment & Regulatory Affairs. Visit [link].
Contributing to Israel’s list of impressive discoveries is a new study, published in Translational Psychiatry , showing that tetrahydrocannabinol (THC) -rich cannabis oil can be effective in treating the symptoms of autism spectrum disorder (ASD). A team of researchers at Tel Aviv University in Tel Aviv, Israel, led by Ph.D.
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.
federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.
If this mechanism is forced to be used repeatedly and often, the body does not properly heal or develop. Often, Post-Traumatic Stress Disorder, a debilitating and chronic illness, can develop. About 10 of every 100 women (or 10%) develop PTSD sometime in their lives compared with about 4 of every 100 men (or 4%).
(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. produced, THC-free 1 CBD products.
MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.
The MoreBetter & CBDistillery CBN study CBN, or cannabinol , is a natural product of THC degradation; it can be found in aged, poorly stored cannabis plants and also in cannabis smoke. Like THC , CBN is a natural anti-inflammatory. What this means for CBN research These results are, in a word, impressive.
Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.
. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.
. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.
A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research. ClinicalTrial Sample Size.
Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.
This synthetic derivative of naturally occurring delta-9-Tetrahydrocannabinol (delta-9-THC) was first reported by noted cannabis chemist Professor Roger Adams at the University of Illinois in 1940. HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant.
In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. THC, CBD & THE ECS. CBD PROMOTES BONE GROWTH. In their summary, the study’s authors noted that.
While another study has shown that patients suffering from IBS involving predominant diarrhea, will benefit most from synthetic tetrahydrocannabinol (THC) known as dronabinol- although we recommend using extreme caution with synthetic cannabinoids. A Neuroscience Researcher Weighs in. Q: How might THC and CBD be able to modulate it? “We
OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinicaltrial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.
“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of ClinicalDevelopment & Regulatory Affairs. Visit [link].
The use of THC (Tetrahydrocannabinol) has surged dramatically over the years with an increasing interest in the potential health benefits for medical marijuana patients. From pain management to mental health, THC is being explored for its therapeutic properties at an unprecedented rate. What is THC?
Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Terpenes interact with both cannabidiol and THC and change the effects that either drug has on the body. Preliminary Research on CBD Oil. CBD is the most abundant active ingredient within the CBD oil.
Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Terpenes interact with both cannabidiol and THC and change the effects that either drug has on the body. Preliminary Research on CBD Oil. CBD is the most abundant active ingredient within the CBD oil.
However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. Still, research is ongoing. Patients can also access CBD products without a prescription through local pharmacies. “Our
As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinicalresearch is extremely difficult to conduct. At this point, it seems seizure disorders respond best to a range of 27:1 to 15:1 CBD: THC full spectrum cannabis oil.
Brains unparalleled expertise and manufacturing capabilities in the CBD space combined with DSM’s unique scientific and marketing capabilities in the pharmaceutical sector make this the ideal partnership to help pharmaceutical players realizing the potential of CBD’s for early stage drug development.’’. ABOUT BRAINS BIOCEUTICAL CORP.
Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures. THC is primarily responsible for the psychoactive effects associated with marijuana, while CBD is known for its therapeutic properties without causing a “high.”
As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Major research hospitals such as Montefiore in New York now use cannabis for treating cancer and HIV, as well as make new studies.
While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.
CBGA is naturally produced by the cannabis plant, and is the precursor to all of the phyto-, or plant-related cannabinoids like THC, CBD, CBN and CBG. Often CBGA is presumed to interact with CB1 and CB2 receptors, more similar to THC and or CBG, but emerging science suggests this is likely not the case. What does CBGA do?
The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. Crohn’s Disease and Marijuana: Efficacy, Research and Dosing. In fact, the risk of developing IBS increases after a gastrointestinal infection for about 10%. Research on cannabis and IBS.
A quarter of all users did not know the strain or THC/CBD content of the product they were using. In their concluding remarks, the study authors noted that “the lack of formal guidance or research evidence about cannabis for Parkinson’s treatment may in part underlie inconsistencies in both use and reported effectiveness.”
According to the 2022 study published in the journal Drug and Alcohol Dependence, researchers found that smoking cannabis accelerates the biological aging process. The researchers decided to make use of a tool known as “ epigenetic clocks” in order to understand whether smoking cannabis accelerates or decreases the aging process.
This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research. Whereas THC is known for its psychoactive effects, CBD is non-psychoactive and has anti-inflammatory and analgesic properties. How Does Medical Marijuana Help Neuropathic Pain?
Researchers believe cannabis contains over 100 unique chemical compounds! But CBD’s stolen the spotlight, partially because of its good cop/bad cop relationship with another famous cannabinoid: T etrahydrocannabinol or THC. THC is responsible for marijuana’s psychoactive effects. What makes CBD special?
Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.
Ripple has incorporated a precise dose of cannabinol (CBN) and THC into the new line of products, allowing consumers to experience the benefits of an unadulterated cannabinoid product without any added sleep aids such as melatonin or valerian root, which can leave the consumer with an unwanted sedative feeling the next day.
However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. While research is still in its early stages, some studies suggest that certain compounds found in cannabis, such as cannabidiol (CBD), may have a positive impact on reducing anxiety and intrusive thoughts associated with OCD.
GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.
It has shown effectiveness in helping individuals develop better sleep habits and manage insomnia symptoms without relying on medication. Key cannabinoids include tetrahydrocannabinol (THC), cannabidiol (CBD), and cannabinol (CBN), each exerting unique effects on the ECS and potentially influencing sleep patterns.
In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.
Accelerated timelines to clinicaltrials and expansion of drug development pipeline. Under the terms of the agreement OCT will use reasonable efforts to develop and commercialise: (i) at least one CBD derivative; (ii) at least one CBG derivative; and (iii) at least one THC derivative, as pharmaceutical drug products.
THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. Shutterstock).
As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Major research hospitals such as Montefiore in New York now use cannabis for treating cancer and HIV, as well as make new studies.
–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content